Aims We estimate trends in severe drug–drug interaction (DDI) prevalence and examine longitudinal associations between DDI exposure and health outcomes (emergency department [ED] visits, quality‐of‐life [QoL] and functional decline) over approximately 10‐years in the older community‐dwelling population in Ireland.
John E. Hughes+2 more
wiley +1 more source
Validation, Content Validity, and Reliability of the Spanish SE-OAM Questionnaire: Assessing Nursing Self-Efficacy in Oral Anticoagulant Therapy Management. [PDF]
de-Moya-Romero JR+5 more
europepmc +1 more source
Anticoagulant therapy in COVID-19: A narrative review. [PDF]
Mohseni Afshar Z+9 more
europepmc +1 more source
Current challenges and future prospects in oral anticoagulant therapy
Julia Czuprynska, J. Patel, R. Arya
semanticscholar +1 more source
Combination vs. single‐drug nonprescription analgesics for acute pain management: A narrative review
Combining nonprescription analgesics with different mechanisms of action has been proposed as a rational strategy to optimize the management of acute pain. This review assessed the efficacy and safety of nonprescription analgesics, including paracetamol (acetaminophen), metamizole and nonsteroidal anti‐inflammatory drugs (NSAIDs) used in combination vs.
Ali Mobasheri+5 more
wiley +1 more source
Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy. [PDF]
Sultana R, Kamihira M.
europepmc +1 more source
Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy [PDF]
Bertrand Condat+4 more
openalex +1 more source
Therapeutic drug monitoring education: The current state
Aims To evaluate available information on therapeutic drug monitoring (TDM) education programmes and their implementation across different countries. Methods The study was performed in two phases. First, a scoping review of scientific literature on available education programmes was performed.
Guenka Petrova+10 more
wiley +1 more source
Anticoagulant and thrombolytic therapy for cerebral embolism of cardiac origin.
Yoshihiro Sato+4 more
openalex +2 more sources
Safety and Cost of Low-Molecular-Weight Heparin as Bridging Anticoagulant Therapy in Subacute Cerebral Ischemia [PDF]
Mary Kalafut+3 more
openalex +1 more source